Clinical Edge Journal Scan

Causal link between Crohn’s disease and PsA exists


 

Key clinical point: Inflammatory bowel disease (IBD), particularly Crohn's disease, is a causal risk factor for psoriatic arthritis (PsA).

Major finding: Genetically predicted IBD was associated with a higher risk for PsA (pooled odds ratio [OR] 1.11; P = .003) with the risk being majorly mediated by Crohn’s disease (OR 1.12; P = .002) and not ulcerative colitis (P = .70).

Study details: Findings are from a bidirectional 2-sample mendelian randomization study including 12,882 patients with IBD and 21,770 matched-controls and 5621 patients with psoriasis and 2063 patients with PsA who were compared with 252,323 controls.

Disclosures: This study did not report any source of funding. The authors declared no conflicts of interest.

Source: Freuer D et al. Association between inflammatory bowel disease and both psoriasis and psoriatic arthritis: A bidirectional 2-sample mendelian randomization study. JAMA Dermatol. 2022 (Sep 14). Doi: 10.1001/jamadermatol.2022.3682

Recommended Reading

Sex differences seen in inflammatory arthritis health care use
Psoriatic Arthritis ICYMI
Analysis of PsA guidelines reveals much room for improvement on conflicts of interest
Psoriatic Arthritis ICYMI
Previous endemic coronavirus encounters linked with long COVID
Psoriatic Arthritis ICYMI
PsA Guidelines
Psoriatic Arthritis ICYMI
A White female presented with pustules and erythematous macules on the left palm
Psoriatic Arthritis ICYMI
Climate change: Commentary in four dermatology journals calls for emergency action
Psoriatic Arthritis ICYMI
JAK inhibitors show no excess cardiovascular safety signal in French nationwide cohort
Psoriatic Arthritis ICYMI
Ten-day methotrexate pause after COVID vaccine booster enhances immunity against Omicron variant
Psoriatic Arthritis ICYMI
Psoriatic arthritis has greater impact on women than men
Psoriatic Arthritis ICYMI
FDA approves upadacitinib (Rinvoq) for sixth indication
Psoriatic Arthritis ICYMI